Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8980833 Tubulysine derivatives

Patent 8980833 was granted and assigned to R&D-Biopharmaceuticals GmbH on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 6 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+135 characters)
Article

Patent abstract

The present invention relates to novel cytotoxic molecules and their use for the treatment of cancer and other diseases.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Wolfgang Richter0
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707532 Compositions and methods of treating muscle dystrophy
0
Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08980833 Tubulysine derivatives US Patent 8980833 Tubulysine derivatives

Infobox
Patent Number
089808330
Patent Number
89808330
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089808330
Edits on 22 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
R&D-Biopharmaceuticals GmbH
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
089808330
Date of Patent
March 17, 2015
0
Patent Application Number
125996630
Date Filed
May 9, 2008
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089808330
Patent Primary Examiner
‌
Karlheinz R. Skowronek
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08980833
Edits on 29 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08980833 Tubulysine derivatives

Infobox
Is a
Patent
Patent
Current assignee
‌
R&D-Biopharmaceuticals GmbH
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08980833
Date of patent
March 17, 2015
Patent application number
12599663
Date Filed
May 9, 2008
Patent primary examiner
‌
Karlheinz R. Skowronek

Find more entities like US Patent 8980833 Tubulysine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo